Health

One dose of an experimental drug may offer lifetime treatment, but its long-term safety is uncertain.

The Trump administration said Friday that it would fully fund SNAP benefits while an appeals process plays out. The Supreme Court then granted its request to pause some of that funding.

The administration has asked a federal appeals court for an emergency pause on a judge's order to fully fund the Supplemental Nutrition Assistance Program.

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.

November payments have been significantly delayed, forcing millions of families who rely on them to go hungry.

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

Doctors say some fevers don't need to be treated, but insist there's no need to fear the commonly used pain reliever.

Kessler will have a procedure to repair a labral tear on Thursday in Los Angeles.

After multiple appeals and denials, Dave Olson pulled a huge portion of the procedure's roughly $100,000 cost from his 401(k).

The lowest doses of Eli Lilly's Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.